Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.59 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.59 |
| ▸ | TTR | P02766 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | RECQL | P46063 | 3/20 | 0.41 |
| ▸ | BLM | P54132 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | APP | P05067 | 2/20 | 0.41 |
| ▸ | SNCA | P37840 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9189207 | 0.84 | AURKA (0.47) | AURKAAURKBTTRCYP1A2ALDH1A1 | |
| SCHEMBL8003311 | 0.83 | AURKB (0.58) | AURKAAURKBTTRCYP1A2NR4A1 | |
| SCHEMBL3194355 | 0.81 | AURKA (0.57) | AURKAAURKBTTRCYP1A2NR4A1 | |
| SCHEMBL5711912 | 0.79 | AURKA (0.77) | AURKAAURKBTTRCYP1A2NR4A1 | |
| SCHEMBL9813360 | 0.79 | AURKA (0.72) | AURKAAURKBTTRCYP1A2NR4A1 | |
| SCHEMBL3211377 | 0.78 | AURKB (0.87) | AURKAAURKBTTRCYP1A2NR4A1 | |
| SCHEMBL10897818 | 0.77 | AURKA (0.65) | AURKAAURKBTTRCYP1A2NR4A1 | |
| SCHEMBL29608931 | 0.77 | AURKB (0.64) | AURKAAURKBTTRCYP1A2NR4A1 | |
| SCHEMBL156055 | 0.77 | AURKB (0.64) | AURKAAURKBTTRCYP1A2NR4A1 | |
| SCHEMBL3505111 | 0.76 | TTR (0.53) | AURKAAURKBTTRCYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103687848-B | Sustainable chemical process for separation of naphthalene sulfonic acid compounds using intrinsic recycle of all acidic streams generated during separation and washing | 布哈德莱什·K·帕迪亚 | 2018-04-24 | — | — | CN | claimed |
| CN-103687848-A | Sustainable chemical process for separation of naphthalene sulfonic acid compounds using intrinsic recycle of all acidic streams generated during separation and washing | PADIA BHADRESH K | 2014-03-26 | — | — | CN | claimed |
| WO-2012147037-A2 | SUSTAINABLE CHEMICAL PROCESS FOR ISOLATION OF NAPHTHALENE SULPHONIC ACID COMPOUNDS WITH INHERENT RECYCLE OF ALL ACIDIC STREAMS GENERATED DURING ISOLATION AND WASHING | PADIA BHADRESH K (IN) | 2012-11-01 | — | — | WO | claimed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | disclosed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | disclosed |
| EP-4440342-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2024-10-09 | — | — | EP | disclosed |
| CN-118714936-A | Methods and uses of microbial compositions, components or metabolites for the treatment of vagal nerve related diseases, disorders and conditions | 奇迹生物公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118265532-A | Methods and uses of microbiome compositions, components or metabolites for treating neurodegenerative diseases | 奇迹生物公司 | 2024-06-28 | — | — | CN | disclosed |
| US-20230190709-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023102149-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2023-06-08 | — | — | WO | disclosed |
| WO-2020142700-A1 | BINDING DOMAIN MAPPING AND COMPOUNDS, COMPOSITIONS, COMPLEXES, METHODS, AND KITS RELATED THERETO | George Mason Research Foundation, Inc. (US) | 2020-07-09 | — | — | WO | disclosed |
| CN-103687848-B | Sustainable chemical process for separation of naphthalene sulfonic acid compounds using intrinsic recycle of all acidic streams generated during separation and washing | 布哈德莱什·K·帕迪亚 | 2018-04-24 | — | — | CN | disclosed |
| US-8764333-B2 | Water based ink compositions for ballpoint pen | THE PILOT INK CO., LTD. (JP) | 2014-07-01 | — | — | US | disclosed |
| CN-103687848-A | Sustainable chemical process for separation of naphthalene sulfonic acid compounds using intrinsic recycle of all acidic streams generated during separation and washing | PADIA BHADRESH K | 2014-03-26 | — | — | CN | disclosed |
| WO-2012147037-A2 | SUSTAINABLE CHEMICAL PROCESS FOR ISOLATION OF NAPHTHALENE SULPHONIC ACID COMPOUNDS WITH INHERENT RECYCLE OF ALL ACIDIC STREAMS GENERATED DURING ISOLATION AND WASHING | PADIA BHADRESH K (IN) | 2012-11-01 | — | — | WO | disclosed |
| US-20100040401-A1 | Water Based Ink Compositions For Ballpoint Pen | THE PILOT INK CO., LTD. (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2123724-A1 | AQUEOUS INK COMPOSITION FOR BALLPOINT PEN | THE PILOT INK CO., LTD. (JP) | 2009-11-25 | — | — | EP | disclosed |
| US-4163675-A | CONTAINING NAPHTHALENE DERIVATIVES | PILOT INK CO., LTD. (JP) | 1979-08-07 | — | — | US | disclosed |
| US-4118232-A | Photographic material containing sulphonic acid group containing disazo dyestuffs | CIBA-GEIGY AG (CH) | 1978-10-03 | — | — | US | disclosed |
| US-4051123-A | Sulfonic-acid-group containing disazo dyestuffs | CIBA-GEIGY AG (CH) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | IAPP, GPR119, FAHD1 | AURKA 2220/4885AURKB 1391/4885TTR 992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.